CBLL | CeriBellNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$28.27
+$1.31 (+4.86%)

CeriBell (CBLL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $28.27 vs 50 $25.06 / 200 $20.83
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Aug 2026 ยท projected 14 bars out

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
above both $28.27 vs 50 $25.94 / 200 $22.34
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

3
crosses on record since 2025
2 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Aug 2026Golden flatdaily14 bars outNot tested
4 Aug 2026Death flatdaily15 bars out6 bar cross test
24 Dec 2025Golden steepdaily27 bars outNot tested

About CBLL

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.